Friday, May 21, 2021

PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:
PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente  —  If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI's (ahem) path forward appears to be paved in gold.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

How Schneider Electric is using AI in call centers and manufacturing to complement employees' work and boost productivity, rather than to replace them (Patricia Cohen/New York Times)

Patricia Cohen / New York Times : How Schneider Electric is using AI in call centers and manufacturing to complement employees' work ...